Bioprocessing Summit Europe to be held March 24-26 The Bioprocessing Summit Europe will return to Barcelona, Spain, this year to address the growing global market for gene therapy and biopharmaceutical manufacturing. The summit will take place from March 24 to 26.
Trump's 2021 budget calls for 8% NIH cut U.S. President Donald Trump on February 10 released a proposed budget for 2021 that includes an 8% cut in funding to the U.S. National Institutes of Health (NIH), proposing a 2021 budget of $38 billion, compared with the $41.4 billion for 2020.
ReForm Biologics, MilliporeSigma ink license agreement ReForm Biologics and MilliporeSigma have signed a licensing agreement to develop and market excipients used for biotherapeutic applications. The agreement dictates that the two firms will research and develop ReForm Biologics' excipients for pharmaceutical use.
Experts map the future of bioprinting Bioprinting has rapidly advanced in both techniques and clinical applications, but key challenges still remain for the burgeoning field. A multinational team of researchers offered their recommendations for how to address these hurdles in an in-depth road map article published February 7 in Biofabrication. Discuss
Hydrogels enable on-demand production of pharmaceuticals A first-in-class system that effectively embeds engineered microbes into the solid support of a 3D-printed hydrogel is described in a report published in Nature Communications on February 4. The hydrogel system organizes both individual microbes and groups of microbes for on-demand production of pharmaceuticals. Discuss
Allen Institute extends cell line contract The Allen Institute for Cell Science announced on February 3 that it has extended its contract with the Coriell Institute for Medical Research for the storage and distribution of its Allen Cell Collection. Since its launch in 2016, the collection has grown from five cell lines to more than 40 lines today. The new agreement between the institutes will extend for an additional three years.